fda bans compounded semaglutide moves to remove GLP-1 medications from 503B Bulks List Ozempic knockoffs flood US market

Generic Semaglutide in Canada: 9 Applications Under Review, but the Timeline Is Slipping Health Canada now has 9 generic semaglutide applications under active review from companies including Sandoz, Apotex, Teva, Taro, and Aspen Pharmacare

thats a lot

It's worth noting that these foods don't need to be completely eliminated from one's diet

We need to have data on that to help us figure out if it makes a difference that theyre also on MHT. In the meantime, Faubion is looking at all her patients who ask about both GLP-1s and MHT carefullyand holistically

In: ISPOR [Internet] 2025

Recently, glucagon-like peptide 1 (GLP-1) agonists have garnered interest for IIH management due to their weight reduction and potential cerebrospinal fluid production-decreasing effects